Artificial Intelligence and protein structures
” This will change medicine.
It will change research.
It will change bioengineering…
It will change everything.”
Nineteen studies were retrieved.
From these, fourteen in silico molecular docking studies demonstrated potential inhibitory properties of artemisinins against coronavirus-host proteins
New tools and technologies
Structural biologists say that their field is in the midst of a revolution: cryo-electron microscopy (cryo-EM)
The Ai Revolution in medicine
In silico and Ethno Pharmacology
Modeling of drug Targets
AI and drug discovery , repurposing.
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics
with omicron both, cathepsin l and TMPRS2 are avaialbe as pathways of entry
difference to viral indicator decline
Real world clinical trials support
the AI driven in silico studies
remarkble synergistic convergence